The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus

Progress in Cardiovascular Diseases

Volumn 58, Issue 1, 2015, Pages 69-75

  Dutton, Gareth R ^a   Lewis, Cora E ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Cardiovascular disease; Lifestyle intervention; Type 2 diabetes mellitus; Weight loss

Indexed keywords

ARTICLE; BLOOD GLUCOSE MONITORING; BODY COMPOSITION; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; FITNESS; HEALTH CARE COST; HEALTH EDUCATION; HUMAN; INCIDENCE; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; QUALITY OF LIFE; RISK REDUCTION; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WALKING; WEIGHT REDUCTION; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; EVIDENCE BASED MEDICINE; EXERCISE; HEALTH STATUS; PREVENTIVE HEALTH SERVICE; PROCEDURES; PROTECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADIPOSITY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; EVIDENCE-BASED MEDICINE; EXERCISE; HEALTH STATUS; HUMANS; OBESITY; PREVENTIVE HEALTH SERVICES; PROTECTIVE FACTORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84937629945     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.04.002     Document Type: Article

References (42)

1. Jensen M.D., Ryan D.H., Apovian C.M., et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol 2013, 63:2985-3023.
2. Field A.E., Barnoya J., Colditz G.A. Epidemiology and health and economic consequences of obesity. Handbook of obesity treatment 2002, 3-18. The Guilford Press, New York. T.A. Wadden, A.J. Stunkard (Eds.).
3. National Heart Lung Blood Institute Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report 1998, NHLBI. NHLBI Obesity Education Initiative Expert Panel (Ed.).
4. Coakley E.H., Kawachi I., Manson J.E., Speizer F.E., Willet W.C., Colditz G.A. Lower levels of physical functioning are associated with higher body weight among middle-aged and older women. Int J Obes Relat Metab Disord 1998, 22(10):958-965.
5. Fine J.T., Colditz G.A., Coakley E.H., et al. A prospective study of weight change and health-related quality of life in women. JAMA 1999, 282(22):2136-2142.
6. Petry N.M., Barry D., Pietrzak R.H., Wagner J.A. Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med 2008, 70(3):288-297.
7. Zhao G., Ford E.S., Dhingra S., Li C., Strine T.W., Mokdad A.H. Depression and anxiety among US adults: associations with body mass index. Int J Obes (Lond) 2009, 33(2):257-266.
8. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298(17):2028-2037.
9. Bauer U.E., Briss P.A., Goodman R.A., Bowman B.A. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet 2014, 384(9937):45-52.
10. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403.
11. Pan X.R., Yang W.Y., Li G.W., Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997, 20(11):1664-1669.
12. Trials of Hypertension Prevention Collaborative Research Group Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The trials of hypertension prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997, 157:657-667.
13. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350.
14. Whelton P.K., Appel L.J., Espeland M.A., et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA 1998, 279(11):839-846.
15. Gregg E.W., Williamson D.F. The relationship of intertional weight loss to disease incidence and mortality. Handbook of obesity treatment 2002, 125-143. The Guilford Press, New York, NY. T.A. Wadden, A.J. Stunkard (Eds.).
16. Schellenberg E.S., Dryden D.M., Vandermeer B., Ha C., Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2013, 159(8):543-551.
17. Yanovski S.Z., Bain R.P., Williamson D.F. Report of a National Institutes of Health-Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons. Am J Clin Nutr 1999, 69(3):366-372.
18. The Look AHEAD Research Group Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003, 24(5):610-628.
19. Look Ahead Research Group, Wadden T.A., West D.S., et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) 2006, 14(5):737-752.
20. Look Ahead Research Group Baseline characteristics of the randomized cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006, 3:202-215.
21. Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013, 369(2):145-154.
22. Brancati F.L., Evans M., Furberg C.D., et al. Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study. Clin Trials 2012, 9(1):113-124.
23. Look AHEAD Research Group Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD Trial. Arch Intern Med 2010, 170(17):1566-1575.
24. Unick J.L., Beavers D., Bond D.S., et al. The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med 2013, 126(3):236-242.
25. Jakicic J.M., Jaramillo S.A., Balasubramanyam A., et al. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes 2009, 33:305-316.
26. Pownall H.J., Bray G.A., Wagenknecht L.E., et al. Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the Look AHEAD Study. Obesity (Silver Spring) 2015, 23(3):565-572.
27. Gregg E.W., Chen H., Wagenknecht L.E., et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012, 308(23):2489-2496.
28. Rubin R.R., Wadden T.A., Bahnson J.L., et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial. Diabetes Care 2014, 37(6):1544-1553.
29. The Look AHEAD Research Group, Knowler W.C., Bahnson J.L., et al. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 2014, 2(10):801-809.
30. Breyer B.N., Phelan S., Hogan P.E., et al. Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial. J Urol 2014, 192(1):144-1499.
31. Phelan S., Kanaya A.M., Subak L.L., et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol 2012, 187(3):939-944.
32. Wing R.R., Rosen R.C., Fava J.L., et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med 2010, 7(Pt 1):156-165.
33. Espeland M.A., Glick H.A., Bertoni A., et al. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care 2014, 37(9):2548-2556.
34. Rejeski W.J., Bray G.A., Chen S.H., et al. Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. J Gerontol A Biol Sci Med Sci 2014, 70(3):343-351.
35. Houston D.K., Leng X., Bray G.A., et al. A long-term intensive lifestyle intervention and physical function: the Look AHEAD Movement and Memory Study. Obesity (Silver Spring) 2015, 23(1):77-84.
36. American Diabetes Association Strategies for improving care. Diabetes Care 2015, 38(Supplement 1):S5-S7.
37. ADVANCE Collaborative Group, Patel A., MacMahon S., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358(24):2560-2572.
38. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139.
39. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559.
40. Unick J.L., Hogan P.E., Neilberg R.H., et al. Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention. Obesity (Silver Spring) 2014, 22(7):1608-1616.
41. Holman R.R., Paul S.K., Bethel A., Matthews D.R., Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-1589.
42. Zoungas A., Chalmers J., Neal B., et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014, 371(15):1392-1406.